GlassScriptPhysician profile
Raymond B Coles
NPI 1255694782
$2,067.74
in general payments reported to CMS, 2019-2025
14 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.53 · 2022: $24.36 · 2023: $503 · 2024: $1,110 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,976.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $889.17 | 2023-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $440.85 | 2023-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $289.80 | 2023-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $110.66 | 2021-2023 | |
| Si-Bone, INC. | $87.22 | 2024-2025 | |
| Valinor Pharma, LLC | $65.41 | 2023-2025 | Movantik |
| Ibsa Pharma INC. | $46.93 | 2024-2025 | Licart, Tirosint, Flector |
| Protega Pharmaceutials INC | $31.22 | 2024 | Roxybond |
| Foundation Fusion Solutions, LLC | $23.74 | 2025 | |
| Abbott Laboratories | $23.55 | 2025 | Octrode |
| Abbvie INC. | $16.57 | 2023 | |
| Alkermes, INC. | $15.30 | 2023 | Vivitrol |
| Vertex Pharmaceuticals Incorporated | $14.18 | 2025 | |
| Spr Therapeutics, INC | $13.14 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Coles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.